S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Leap Therapeutics Inc (LPTX)
Leap Therapeutics Inc (LPTX) Financials

Leap Therapeutics Inc (LPTX)

2.92

0.27

(10.19%)

At close: November 27 3:00PM

Delayed by 15 minutes

3.01

0.09

( 3.08% )

After Hours: 4:30PM

Delayed by 15 minutes

Leap Therapeutics Inc Financial Summary

The current LPTX market cap is 115.34M. The company's latest EPS is USD -2.1247 and P/E is -1.37.

Income Statement

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0	0	0
Operating Income	-14.66M	-14.83M	-14.82M	-14.83M	-21.25M
Net Income	-13.39M	-13.7M	-12.47M	-13.82M	-20.13M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	1.5M	1.5M	0	0
Operating Income	-33.45M	-28.54M	-41.43M	-56.76M	-87.04M
Net Income	-33.26M	-37.59M	-40.59M	-54.6M	-81.41M

Balance Sheet

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	95.86M	83.05M	72.83M	57.96M	81.43M
Total Liabilities	11.8M	11.04M	12.68M	10.59M	15.64M
Total Equity	84.06M	72.01M	60.14M	47.37M	65.79M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	7.45M	54.37M	117.91M	70.35M	72.83M
Total Liabilities	9.2M	7.72M	10.02M	11.49M	12.68M
Total Equity	-1.75M	46.65M	107.89M	58.87M	60.14M

Cash Flow

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-22.89M	-33.37M	-43.75M	-15.52M	-29.19M
Investing	48.97M	48.97M	48.97M	N/A	N/A
Financing	-29k	-30k	-30k	29k	37.15M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-26.9M	-25.96M	-35.16M	-49.04M	-43.75M
Investing	-85k	25k	N/A	N/A	48.97M
Financing	14.82M	74M	98.04M	-210k	-30k

Stats and Ratios

Market Cap	115.34M
Price to Earnings Ratio	-1.37
Price to Sales Ratio	0
Price to Cash Ratio	1.58
Price to Book Ratio	1.85
Dividend Yield	-

Share Statistics

Shares Outstanding	38.32M
Average Volume (1 week)	391.99k
Average Volume (1 Month)	342.42k
52 Week Change	18.04%
52 Week High	5.00
52 Week Low	1.68
Spread (Intraday)	0.18 (5.81%)

Company Info

Company Name	Leap Therapeutics Inc
Address	251 little falls drive wilmington, delaware 19808
Website	https://www.leaptx.com
Industry	pharmaceutical preparations (2834)

Leap Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions